Q-Chip launches unique technology

BIO 2004 saw the launch of a unique technology for the fully scalable manufacture of micro- and nanoparticles.

Q Chip, a start-up company based in Cardiff, UK, can achieve complex encapsulations and precision morphologies in particles at <1% size variation, with exciting applications in the development of novel 'smart therapeutics'.

Q Chip's unique microfluidic system exploits the hydrophobic properties of polymer-based substrates enabling the large-scale, precision manufacture of high value microparticles, which would not be possible if performed in conventional large vessels.

Through precise particle engineering Q Chip can extend patent life, increase shelf life and open up new delivery methods such as inhaled versions of drugs that are currently injected - eg insulin therapy.

'It is no exaggeration to say that our technology can have a major impact on a company's business, and with potential applications in the biopharma, food and cosmetic industries the opportunities are far ranging' said Dr Jo Daniels, Q Chip's business development Director. 'For example particle size control is extremely important for pulmonary delivered therapeutics. Q Chip's technology produces particles in a very narrow size range (less than 1%) and for the first time offers a micronisation process capable of producing 2 µm protein particles - this gives a real indication of the power and possibilities of the technology.'

The technology can be applied across numerous disciplines and industry sectors and in the first instance Q Chip are concentrating on applying the technology to polymers (medical devices), bioencapsulates (functional foods, cosmetics) and proteins (pharmaceutical). Dr Daniels continued: 'We have already received interest from a number of multinational companies and we are actively seeking further partnering opportunities.'